🔗 Permalink

Inventor profile of:

Derek JANTZ

City:

Durham, North Carolina

Country:

United States

Published Applications:

147

Last publication date:

2026-05-14

Top Assignees for applications by Derek JANTZ

The entities that hold a legal rights for patent applications filed by inventor JANTZ Derek:

PRECISION BIOSCIENCES, INC. 98 Durham, NC United States
DUKE UNIVERSITY 25 Durham, NC United States
PIONEER HI BRED INTERNATIONAL INC 7 Johnston, IA United States
E. I. DU PONT DE NEMOURS AND COMPANY 4 Wilmington, DE United States
DUKE UNIVERSITY 3 Research Triangle Park, NC United States
PRECISION BIOSCIENCES, INC. 3 Research Triangle Park, NC United States
E.I. DU PONT DE NEMOURS AND COMPANY 3 Wilmington, DE United States
PIONEER HI-BRED INTERNATIONAL, INC. 2 , IA United States
University of Miami 1 Miami, FL United States
CORTEVA AGRISCIENCE, LLC 1 , IN United States
Corteva Agriscience LLC 1 Indianapolis, IN United States
Precision BioSciencens, Inc. 1 Durham, NC United States
North Carolina State University 1 Raleigh, NC United States

Recent patent applications by JANTZ Derek

Derek JANTZ from Durham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-14

US20260132376A1

Chemistry; metallurgy

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

#2 | 2025-12-25

US20250388884A1

Chemistry; metallurgy

RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY

#3 | 2025-11-13

US20250346874A1

Chemistry; metallurgy

FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS

#4 | 2025-10-09

US20250313816A1

Chemistry; metallurgy

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED TRANSFERRIN GENE

#5 | 2025-10-02

US20250304949A1

Chemistry; metallurgy

GENETIC MODIFICATION OF THE HYDROXYACID OXIDASE 1 GENE FOR TREATMENT OF PRIMARY HYPEROXALURIA

#6 | 2025-09-04

US20250277227A1

Chemistry; metallurgy

METHODS FOR PRODUCING A COMPLEX TRANSGENIC TRAIT LOCUS

#7 | 2025-05-15

US20250154486A1

Chemistry; metallurgy

ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME

#8 | 2025-05-15

US20250154485A1

Chemistry; metallurgy

RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES

#9 | 2025-05-15

US20250154481A1

Chemistry; metallurgy

ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE PCSK9 GENE

#10 | 2025-05-15

US20250152679A1

Human necessities

DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES

#11 | 2025-04-17

US20250121039A1

Human necessities

TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES

#12 | 2025-03-13

US20250082735A1

Human necessities

PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES

#13 | 2025-01-30

US20250034536A1

Chemistry; metallurgy

POLYNUCLEOTIDES ENCODING ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR RECOGNITION SEQUENCES IN THE DYSTROPHIN GENE

#14 | 2025-01-23

US20250027065A1

Chemistry; metallurgy

ENGINEERED NUCLEASES THAT TARGET HUMAN AND CANINE FACTOR VIII GENES AS A TREATMENT FOR HEMOPHILIA A

#15 | 2024-12-05

US20240401110A1

Chemistry; metallurgy

RECOGNITION SEQUENCES FOR I-CREI-DERIVED MEGANUCLEASES AND USES THEREOF

#16 | 2024-11-21

US20240382526A1

Human necessities

NUCLEIC ACIDS ENCODING ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

#17 | 2024-08-15

US20240271111A1

Chemistry; metallurgy

ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME

#18 | 2024-07-18

US20240238387A1

Human necessities

TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES

#19 | 2024-07-11

US20240228994A9

Chemistry; metallurgy

RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY

#20 | 2024-07-11

US20240228992A1

Chemistry; metallurgy

FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS

#21 | 2024-06-20

US20240200046A1

Chemistry; metallurgy

ENGINEERED MEGANUCLEASES THAT TARGET HUMAN MITOCHONDRIAL GENOMES

#22 | 2024-05-16

US20240156919A1

Human necessities

DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES

#23 | 2024-05-02

US20240141311A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR GENERATING MALE STERILE PLANTS

#24 | 2024-04-25

US20240132862A1

Chemistry; metallurgy

RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY

#25 | 2024-03-28

US20240101986A1

Chemistry; metallurgy

ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE PCSK9 GENE

#26 | 2024-03-28

US20240101985A1

Chemistry; metallurgy

ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE PCSK9 GENE

#27 | 2024-02-15

US20240052373A1

Chemistry; metallurgy

ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE

#28 | 2024-01-18

US20240018495A1

Chemistry; metallurgy

Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

#29 | 2024-01-18

US20240018215A1

Human necessities

CO-STIMULATORY DOMAINS FOR USE IN GENETICALLY-MODIFIED CELLS

#30 | 2024-01-11

US20240011003A1

Chemistry; metallurgy

ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE TRANSTHYRETIN GENE

#31 | 2024-01-04

US20240002823A1

Chemistry; metallurgy

Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

#32 | 2024-01-04

US20240002796A1

Chemistry; metallurgy

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

#33 | 2023-12-28

US20230416711A1

Chemistry; metallurgy

RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES

#34 | 2023-07-27

US20230235342A1

Chemistry; metallurgy

METHODS FOR PRODUCING A COMPLEX TRANSGENIC TRAIT LOCUS

#35 | 2023-06-29

US20230201317A1

Human necessities

PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES

#36 | 2023-06-22

US20230193318A1

Chemistry; metallurgy

SELF-LIMITING VIRAL VECTORS ENCODING NUCLEASES

#37 | 2023-06-22

US20230193230A1

Chemistry; metallurgy

TREATMENT OF RETINITIS PIGMENTOSA USING IMPROVED ENGINEERED MEGANUCLEASES

#38 | 2023-06-22

US20230190780A1

Human necessities

METHODS FOR IMMUNOTHERAPY

#39 | 2023-06-15

US20230183664A1

Chemistry; metallurgy

SELF-LIMITING VIRAL VECTORS ENCODING NUCLEASES

#40 | 2023-06-08

US20230174621A1

Chemistry; metallurgy

MODIFIED EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDES FOR USE IN GENETICALLY-MODIFIED CELLS

#41 | 2023-03-23

US20230088311A1

Chemistry; metallurgy

RECOGNITION SEQUENCES FOR I-CREI-DERIVED MEGANUCLEASES AND USES THEREOF

#42 | 2023-02-16

US20230053176A1

Chemistry; metallurgy

Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

#43 | 2023-02-02

US20230036065A1

Human necessities

METHODS FOR CANCER IMMUNOTHERAPY

#44 | 2022-10-20

US20220333137A1

Chemistry; metallurgy

METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES

#45 | 2022-08-04

US20220243187A1

Chemistry; metallurgy

ENGINEERED MEGANUCLEASES SPECIFIC FOR RECOGNITION SEQUENCES IN THE HEPATITIS B VIRUS GENOME

#46 | 2022-07-21

US20220228115A1

Chemistry; metallurgy

NUCLEIC ACID MOLECULES ENCODING AN ENGINEERED ANTIGEN RECEPTOR AND AN INHIBITORY NUCLEIC ACID MOLECULE AND METHODS OF USE THEREOF

#47 | 2022-06-23

US20220193267A1

Human necessities

ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A

#48 | 2022-05-19

US20220152112A1

Human necessities

NUCLEIC ACIDS ENCODING ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

#49 | 2022-05-12

US20220145251A1

Chemistry; metallurgy

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

#50 | 2022-05-12

US20220143155A1

Human necessities

TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES

#51 | 2022-05-05

US20220135945A1

Chemistry; metallurgy

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

#52 | 2022-04-21

US20220119786A1

Chemistry; metallurgy

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED TRANSFERRIN GENE

#53 | 2022-03-24

US20220090047A1

Chemistry; metallurgy

GENETIC MODIFICATION OF THE HYDROXYACID OXIDASE 1 GENE FOR TREATMENT OF PRIMARY HYPEROXALURIA

#54 | 2021-10-28

US20210332338A1

Chemistry; metallurgy

FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS

#55 | 2021-09-16

US20210284980A1

Chemistry; metallurgy

RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY

#56 | 2021-09-09

US20210277373A1

Chemistry; metallurgy

GENETICALLY-MODIFIED T CELLS COMPRISING A MODIFIED INTRON IN THE T CELL RECEPTOR ALPHA GENE

#57 | 2021-07-29

US20210228693A1

Human necessities

PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES

#58 | 2021-07-08

US20210207093A1

Chemistry; metallurgy

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

#59 | 2021-06-17

US20210180038A1

Chemistry; metallurgy

Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome

#60 | 2021-05-20

US20210145940A1

Human necessities

DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES

#61 | 2021-05-06

US20210130874A1

Chemistry; metallurgy

RECOGNITION SEQUENCES FOR I-CREI-DERIVED MEGANUCLEASES AND USES THEREOF

#62 | 2021-03-04

US20210062201A1

Chemistry; metallurgy

Methods for producing a complex transgenic trait locus

#63 | 2021-02-25

US20210054354A1

Chemistry; metallurgy

RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES

#64 | 2021-02-25

US20210052650A1

Human necessities

Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene

#65 | 2021-02-04

US20210032664A1

Chemistry; metallurgy

ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE

#66 | 2021-01-07

US20210000928A1

Human necessities

TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES

#67 | 2020-12-24

US20200399346A1

Chemistry; metallurgy

CO-STIMULATORY DOMAINS FOR USE IN GENETICALLY-MODIFIED CELLS

#68 | 2020-10-29

US20200339952A1

Chemistry; metallurgy

NUCLEIC ACID MOLECULES ENCODING AN ENGINEERED ANTIGEN RECEPTOR AND AN INHIBITORY NUCLEIC ACID MOLECULE AND METHODS OF USE THEREOF

#69 | 2020-10-01

US20200308602A1

Chemistry; metallurgy

SELF-LIMITING VIRAL VECTORS ENCODING NUCLEASES

#70 | 2020-09-24

US20200299658A1

Chemistry; metallurgy

ENGINEERED NUCLEASES THAT TARGET HUMAN AND CANINE FACTOR VIII GENES AS A TREATMENT FOR HEMOPHILIA A

#71 | 2020-07-30

US20200239864A1

Chemistry; metallurgy

Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome

#72 | 2020-07-30

US20200239544A1

Chemistry; metallurgy

MODIFIED EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDES FOR USE IN GENETICALLY-MODIFIED CELLS

#73 | 2020-06-11

US20200179495A1

Human necessities

Treatment of retinitis pigmentosa using engineered meganucleases

#74 | 2020-04-30

US20200131489A1

Chemistry; metallurgy

Engineered meganucleases specific for recognition sequences in the PCSK9 gene

#75 | 2020-04-23

US20200123516A1

Chemistry; metallurgy

Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene

#76 | 2020-04-09

US20200109384A1

Chemistry; metallurgy

FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS

#77 | 2020-04-09

US20200109383A1

Chemistry; metallurgy

RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY

#78 | 2020-02-27

US20200063102A1

Chemistry; metallurgy

Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof

#79 | 2020-01-30

US20200031904A1

Chemistry; metallurgy

Co-stimulatory domains for use in genetically-modified cells

#80 | 2019-12-05

US20190365870A1

Human necessities

DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES

#81 | 2019-09-19

US20190284543A1

Chemistry; metallurgy

Engineered meganucleases specific for recognition sequences in the hepatitis B virus genome

#82 | 2019-09-05

US20190269762A1

Human necessities

DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES

#83 | 2019-08-15

US20190249199A1

Chemistry; metallurgy

METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES

#84 | 2019-08-01

US20190233500A1

Chemistry; metallurgy

Co-stimulatory domains for use in genetically-modified cells

#85 | 2019-06-27

US20190194729A1

Chemistry; metallurgy

RECOGNITION SEQUENCES FOR I-CREI-DERIVED MEGANUCLEASES AND USES THEREOF

#86 | 2019-06-27

US20190194616A1

Chemistry; metallurgy

GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE

#87 | 2019-05-16

US20190142973A1

Human necessities

Engineered nucleases useful for treatment of hemophilia A

#88 | 2019-01-17

US20190017075A1

Chemistry; metallurgy

ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN BETA-2 MICROGLOBULIN GENE

#89 | 2018-12-06

US20180344817A1

Human necessities

PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES

#90 | 2018-11-29

US20180340160A1

Chemistry; metallurgy

RATIONALLY-DESIGNED SINGLE-CHAIN MEGANUCLEASES WITH NON-PALINDROMIC RECOGNITION SEQUENCES

#91 | 2018-10-25

US20180305706A1

Chemistry; metallurgy

Methods for producing a complex transgenic trait locus

#92 | 2018-10-11

US20180289741A1

Human necessities

Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene

#93 | 2018-09-20

US20180265845A1

Chemistry; metallurgy

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

#94 | 2018-09-13

US20180258392A1

Chemistry; metallurgy

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

#95 | 2018-09-06

US20180250370A1

Human necessities

Treatment of retinitis pigmentosa using engineered meganucleases

#96 | 2018-06-21

US20180171357A1

Chemistry; metallurgy

Self-limiting viral vectors encoding nucleases

#97 | 2018-06-14

US20180163233A1

Chemistry; metallurgy

METHODS AND PRODUCTS FOR PRODUCING ENGINEERED MAMMALIAN CELL LINES WITH AMPLIFIED TRANSGENES

#98 | 2018-05-24

US20180140635A1

Human necessities

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

#99 | 2018-05-17

US20180133254A1

Human necessities

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

#100 | 2018-05-15

US15865089

Chemistry; metallurgy

Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

InventorID:

415084 ⎘